midazolam has been researched along with Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rett syndrome is a severe neurodevelopmental disease caused by mutations of the transcriptional repressor methyl-CpG-binding protein 2 (MeCP2) that induce complex, disabling symptoms, including breathing symptoms." | 1.37 | The benzodiazepine Midazolam mitigates the breathing defects of Mecp2-deficient mice. ( Hilaire, G; Voituron, N, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Voituron, N | 1 |
| Hilaire, G | 1 |
1 other study available for midazolam and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome
| Article | Year |
|---|---|
The benzodiazepine Midazolam mitigates the breathing defects of Mecp2-deficient mice.
Topics: Animals; Benzodiazepines; Disease Models, Animal; GABA Agonists; gamma-Aminobutyric Acid; Methyl-CpG | 2011 |